Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Boston, November 6-11, 2007
Honolulu, September 14-19, 2007
Barcelona, June 13-16, 2007
Affiliations
MSK Report News
MSK Video Report:
Philip Conaghan, MD presents "Clinical Research using MRI as an Endpoint: A Review of the Literature" at the 2009 International Society of Extremity MRI in Rheumatology Conference in Miami, Florida
Marc Cohen, MD presents "Hot Topic: Vasculitis Update" at the 2009 Rheumatology Winter Clinical Symposium in Maui, Hawaii
Thursday, July 02, 2009
Consumer News:
FDA Panel Recommends a Lower Maximum Daily Dose of Tylenol
A panel of experts assembled by the US FDA has recommended that the daily maximum dose of acetaminophen (Tylenol) be lowered to prevent liver damage...
Thursday, July 02, 2009
Arthritis:
Lung Study Questions Leflunomide Safety in RA
Rheumatologists who routinely use leflunomide in rheumatoid arthritis patients should be on the look-out for early signs of lung disease...
Wednesday, July 01, 2009
Arthritis:
Masitinib Pilot Study Shows Promise in DMARD-resistant RA
The first drug to target mast cells in RA shows promising early results in an uncontrolled phase 2a trial...
Tuesday, June 30, 2009
Consumer News:
Assessment of Bone Growth Stimulator Is Mixed
Bone-morphogenic protein (BMP) is being increasingly used in the US to stimulate the creation of new bone during spinal fusion surgery, despite higher costs and complication rates...
Friday, June 26, 2009
EULAR 2009:
Gum Disease Prominent in RA, but TNF-Blockade Can Help
Three new studies shed light on the connection between rheumatoid arthritis (RA) and periodontitis, and new data help define a role for TNF-blockade in improving periodontal status as well as RA signs and symptoms...
Thursday, June 25, 2009
EULAR 2009:
Pegloticase Shrinks Tophi Even in Resistant Gout
Pegloticase significantly reduced tophus size in 40% of treatment-failure gout patients...
Thursday, June 25, 2009
EULAR 2009:
From Inflammation to Bone Formation in SpA
Clinical and animal data reported at EULAR suggest that both controlling inflammation and preventing new bone formation may be required to stop ankylosing spondylitis progression...
BioPharm Business News
Thursday, June 18, 2009
Biogen Gets Joint Control of Genentech Post-Rituxan Development
Genentech must stop three drug development projects but can continue lupus and RA ocrelizumab studies....
Monday, June 15, 2009
Waxman Wants to Let FDA OK Biosimilars Without Legal Authority
Rep. Henry Waxman asks White House to let FDA approve generic biologics...
Friday, June 05, 2009
FDA OKs 2-Year Reclast for Osteoporosis
Reclast (zoledronic acid) injection has been approved as the first therapy to prevent osteoporosis for 2 years with a single dose...
Friday, May 29, 2009
NIH Pops $24M into Orphan Diseases Research
NIH will put $24 million into a new program for developing drugs for rare and neglected diseases...
Thursday, May 28, 2009
Supreme Court to Hear Vioxx Case
The US Supreme Court will decide whether Merck should be protected from Vioxx shareholder suits...
